APOLIPOPROTEIN-E MESSENGER-RNA IN THE BRAINS OF PATIENTS WITH ALZHEIMERS-DISEASE

被引：56
|
作者：
YAMADA, T
KONDO, A
TAKAMATSU, J
TATEISHI, J
GOTO, I
机构：
[1] HIZEN NATL MENTAL HOSP, CTR EMOT & BEHAV DISORDERS, KANZAKI, SAGA 84201, JAPAN
[2] KYUSHU UNIV 60, FAC MED, INST NEUROL, DEPT NEUROPATHOL, FUKUOKA 812, JAPAN
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 1995年 / 129卷 / 01期
关键词：
ALZHEIMERS DISEASE; APOLIPOPROTEIN E; GLIAL FIBRILLARY ACIDIC PROTEIN; PCR;
D O I：
10.1016/0022-510X(94)00249-N
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
To clarify the role of apolipoprotein E (apoE) in the pathophysiology of Alzheimer's disease (AD), we used an RT-PCR method to investigate apoE and glial fibrillary acidic protein (GFAP) mRNA expression in the brain. ApoE mRNA was significantly more abundant in AD (0.379 +/- 0.191, mean +/- SD) than in control (0.125 +/- 0.073, p < 0.05) brain tissue, but in AD it was decreased in relation to the apoE-epsilon 4 gene dosage. The GFAP mRNA content also was greater in AD (5.96 +/- 2.94) than in control (3.80 +/- 2.78) tissue, and in AD showed an increase relative to the apoE-epsilon 4 gene dosage. AD patients who had long survival times showed high expression of apoE and low expression of GFAP. These results suggest that apoE suppresses the progression of AD, including gliosis, in the brain.
引用
收藏
页码：56 / 61
页数：6
相关论文
共 50 条
  • [41] APOLIPOPROTEIN-E GENOTYPING IN THE DIFFERENTIAL-DIAGNOSIS, NOT PREDICTION, OF ALZHEIMERS-DISEASE
    ROSES, AD
    ANNALS OF NEUROLOGY, 1995, 38 (01) : 6 - 14
  • [42] FIBRILLOGENESIS IN ALZHEIMERS-DISEASE OF AMYLOID-BETA PEPTIDES AND APOLIPOPROTEIN-E
    CASTANO, EM
    PRELLI, F
    WISNIEWSKI, T
    GOLABEK, A
    KUMAR, RA
    SOTO, C
    FRANGIONE, B
    BIOCHEMICAL JOURNAL, 1995, 306 : 599 - 604
  • [43] APOLIPOPROTEIN-E GENOTYPE IN PATIENTS WITH ALZHEIMERS-DISEASE - IMPLICATIONS FOR THE RISK OF DEMENTIA AMONG RELATIVES
    FARRER, LA
    CUPPLES, LA
    VANDUIJN, CM
    KURZ, A
    ZIMMER, R
    MULLER, U
    GREEN, RC
    CLARKE, V
    SHOFFNER, R
    WALLACE, DC
    CHUI, H
    FLANAGAN, SD
    DUARA, R
    STGEORGEHYSLOP, P
    AUERBACH, SA
    VOLICER, L
    WELLS, JM
    VAN BROECKHOVEN, C
    GROWDON, JH
    HAINES, JL
    ANNALS OF NEUROLOGY, 1995, 38 (05) : 797 - 808
  • [44] APOLIPOPROTEIN-E IN ANIMAL-MODELS OF CNS INJURY AND IN ALZHEIMERS-DISEASE
    POIRIER, J
    JOURNAL OF NEUROCHEMISTRY, 1995, 65 : S208 - S208
  • [45] A DECISIVE BREAKTHROUGH IN EPIDEMIOLOGIC GENETICS OF ALZHEIMERS-DISEASE - THE ROLE OF APOLIPOPROTEIN-E
    DREYFUS, JC
    M S-MEDECINE SCIENCES, 1993, 9 (10): : 1142 - 1143
  • [46] APOLIPOPROTEIN-E IN ANIMAL-MODELS OF CNS INJURY AND IN ALZHEIMERS-DISEASE
    POIRIER, J
    TRENDS IN NEUROSCIENCES, 1994, 17 (12) : 525 - 530
  • [47] APOLIPOPROTEIN-E IN SPORADIC ALZHEIMERS-DISEASE - ALLELIC VARIATION AND RECEPTOR INTERACTIONS
    REBECK, GW
    REITER, JS
    STRICKLAND, DK
    HYMAN, BT
    NEURON, 1993, 11 (04) : 575 - 580
  • [48] HEAD-INJURY AND RISK OF ALZHEIMERS-DISEASE BY APOLIPOPROTEIN-E GENOTYPE
    OMEARA, E
    KUKULL, WA
    SCHELLENBERG, GD
    BOWEN, JD
    MCCORMICK, WC
    TERI, L
    PFANSCHMIDT, M
    THOMPSON, JD
    LARSON, EB
    NEUROLOGY, 1995, 45 (04) : A327 - A327
  • [49] EXPLAINING THE COLOCALIZATION OF APOLIPOPROTEIN-E AND BETA-AMYLOID IN ALZHEIMERS-DISEASE
    BASHEERUDDIN, K
    LEE, J
    ALFIERI, E
    FARALDI, F
    ILANGOVAN, S
    REYES, MG
    FASEB JOURNAL, 1995, 9 (03): : A383 - A383
  • [50] ASSOCIATION STUDY OF APOLIPOPROTEIN-E AND SPORADIC ALZHEIMERS-DISEASE IN THE JAPANESE POPULATION
    YOSHIIWA, A
    KAMINO, K
    MIKI, T
    NAGANO, K
    NONOMURA, Y
    YONEDA, H
    SAKAI, T
    OGIHARA, T
    NEUROBIOLOGY OF AGING, 1994, 15 : S132 - S133
12345